Andrew Karter to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications Andrew Karter has written about Dipeptidyl-Peptidase IV Inhibitors.
Connection Strength
0.348
-
GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. Alzheimers Dement. 2025 Sep; 21(9):e70621.
Score: 0.231
-
Medication adherence and persistence of newly initiated medications in older adults with diabetes. J Am Pharm Assoc (2003). 2026 May-Jun; 66(3):103075.
Score: 0.060
-
Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes. JAMA Netw Open. 2025 10 01; 8(10):e2536100.
Score: 0.058